| |
No. of patients (%)
|
Mean age, years (standard deviation)
|
Gender
|
Immune status
| |
|---|
|
Immuno-compromised (%)
|
Immuno-competent (%)
|
Total
|
|---|
|
Male (%)
|
Female (%)
|
|---|
|
Indigenous
|
53 (29.1)
|
43.4 (17.9)
|
31 (58.4)
|
22 (41.5)
|
35 (66.0)
|
18 (34.0)
|
53
|
|
Death count
| | | | |
1 (25.0)
|
3 (75.0)
|
4
|
|
Case-fatality rate (%)
| | | | |
2.9
|
16.7
|
7.5
|
|
Non-indigenous
|
129 (70.9)
|
62.7 (14.3)
|
73 (56.6)
|
56 (43.4)
|
38 (29.5)
|
91 (70.5)
|
129
|
|
Death count
| | | | |
5 (45.5)
|
6 (54.5)
|
11
|
|
Case-fatality rate (%)
| | | | |
13.2
|
6.6
|
8.5
|
|
p values*
| |
< 0.001
|
0.58
|
0.35
|
0.21
|
0.17
|
1.00
|
- *p values for difference between indigenous and non-indigenous values. Statistical analysis: Fisher Exact test (gender, death counts among immunocompromised, immunocompetent, and total); t-test (mean age). α = 0.05
